share_log

D: Filing D

D: Filing D

D：發行公告
美股SEC公告 ·  10/09 16:17

Moomoo AI 已提取核心訊息

Clene Inc., a biopharmaceutical company incorporated in Delaware, has filed a Form D Notice of Exempt Offering of Securities with the SEC, indicating a new notice for an equity offering. The filing, dated October 1, 2024, reports that the company has successfully raised $7,310,060 USD through the sale of securities. The offering, which did not last more than one year, included equity, options, warrants, and other rights to acquire additional securities. Clene Inc. has declined to disclose the issuer size in terms of revenue or aggregate net asset value. The company has also claimed an exemption under Rule 506(b) of the Securities Act. The filing lists several executive officers and directors, including President and CEO Robert Etherington, who signed the submission on October 9, 2024. No sales commissions or finders' fees were reported, and the proceeds from the offering are not intended for payments to the named executive officers, directors, or promoters.
Clene Inc., a biopharmaceutical company incorporated in Delaware, has filed a Form D Notice of Exempt Offering of Securities with the SEC, indicating a new notice for an equity offering. The filing, dated October 1, 2024, reports that the company has successfully raised $7,310,060 USD through the sale of securities. The offering, which did not last more than one year, included equity, options, warrants, and other rights to acquire additional securities. Clene Inc. has declined to disclose the issuer size in terms of revenue or aggregate net asset value. The company has also claimed an exemption under Rule 506(b) of the Securities Act. The filing lists several executive officers and directors, including President and CEO Robert Etherington, who signed the submission on October 9, 2024. No sales commissions or finders' fees were reported, and the proceeds from the offering are not intended for payments to the named executive officers, directors, or promoters.
Clene Inc.，一家在特拉華州註冊成立的生物製藥公司，向美國證券交易委員會提交了《免登記證券發行通知表D》，表明對股權發行進行了新的通知。文件日期爲2024年10月1日，報告顯示該公司通過證券銷售成功籌集了7,310,060美元。這一發行不超過一年，包括股權、期權、warrants和其他獲取額外證券的權利。Clene Inc.拒絕披露按營業收入或累計淨資產價值計算的發行人規模。該公司還聲稱根據《證券法》第506(b)規則獲得了豁免。該申報列出了幾位高級主管和董事，包括總裁兼首席執行官羅伯特·埃瑟靈頓，他於2024年10月9日簽署了提交申請。沒有報告銷售佣金或中介費，募集資金不用於支付給指定的高管、董事或推廣者。
Clene Inc.，一家在特拉華州註冊成立的生物製藥公司，向美國證券交易委員會提交了《免登記證券發行通知表D》，表明對股權發行進行了新的通知。文件日期爲2024年10月1日，報告顯示該公司通過證券銷售成功籌集了7,310,060美元。這一發行不超過一年，包括股權、期權、warrants和其他獲取額外證券的權利。Clene Inc.拒絕披露按營業收入或累計淨資產價值計算的發行人規模。該公司還聲稱根據《證券法》第506(b)規則獲得了豁免。該申報列出了幾位高級主管和董事，包括總裁兼首席執行官羅伯特·埃瑟靈頓，他於2024年10月9日簽署了提交申請。沒有報告銷售佣金或中介費，募集資金不用於支付給指定的高管、董事或推廣者。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間